Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Anglo American Platinum Ltd American Depositary Receipts - S | RPH1 | Nov 25, 2024 | 5.15 | -2.83 |
Anglo American PLC | NGLB | Nov 25, 2024 | 28.77 | +1.41 |
Anglo American plc Sponsored ADR (United Kingdom) | NGLD | Nov 25, 2024 | 14.10 | +2.17 |
Anglo Asian Mining | A4A | Nov 25, 2024 | 1.10 | 0.00 |
Anglo Pacific Group PLC | HGR | Nov 25, 2024 | 0.78 | +2.75 |
Angus Energy Plc | A3R | Nov 25, 2024 | 0.00 | 0.00 |
Anheuser-Busch Inbev SA Sponsored ADR (Belgium) | ITKA | Nov 25, 2024 | 52.00 | 0.00 |
Anheuser-Busch InBev SA/NV | 1NBA | Nov 25, 2024 | 52.84 | +0.65 |
ANHUI CONCH | AQE | Nov 25, 2024 | 2.46 | -1.01 |
ANHUI CONCH CEM.ADR/5 YC1 | AQE0 | Nov 25, 2024 | 12.10 | -3.20 |
Anhui Expressway Co | HU7 | Nov 25, 2024 | 1.07 | -0.93 |
ANI Pharmaceuticals, Inc. | BSFA | Nov 25, 2024 | 53.50 | +0.94 |
Anika Therapeutics Inc. | AKP | Nov 25, 2024 | 15.80 | -1.86 |
Anima Holding | 124 | Nov 25, 2024 | 6.05 | +1.17 |
Annaly Capital Management | AAYA | Nov 25, 2024 | 19.07 | +0.34 |
ANNEXIN PHARM. AB (PUBL) | Q91 | Nov 25, 2024 | 0.03 | +1.32 |
Annovis Bio, Inc. | 07X | Nov 25, 2024 | 6.50 | +1.56 |
Anonymous Intelligence | 1JIA | Nov 25, 2024 | 0.08 | -6.40 |
ANORTECH RES INC. | HR50 | Nov 25, 2024 | 0.01 | +5.56 |
Anoto Group | XTL1 | Nov 25, 2024 | 0.01 | +8.93 |
Anritsu Corporation | AN1 | Nov 25, 2024 | 7.10 | +0.71 |
Ansell Ltd. | PD1A | Nov 25, 2024 | 20.20 | +1.00 |
Ansell Ltd. | PD1 | Nov 25, 2024 | 74.50 | +1.36 |
Anson Resources Limited | 9MY | Nov 25, 2024 | 0.03 | -6.89 |
Answear.com S.A. | 90Z | Nov 25, 2024 | 5.46 | +3.41 |
ANSYS, Inc. | AKX | Nov 25, 2024 | 334.40 | +0.84 |
ANT.(RMB)CL.B HKD -,1 | 9MD0 | Nov 25, 2024 | 8.85 | -2.75 |
ANTA SPORTS | AS7 | Nov 25, 2024 | 9.55 | -0.09 |
Antares Vision S.p.a. | 2YK | Nov 25, 2024 | 2.93 | +0.86 |
Antengene Corporation Limited | 722 | Nov 25, 2024 | 0.05 | +5.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.